I doubt it. The major holders of Diatreme are Chinese and they'll take over, not sell, as China wants the product. They'll concentrate and ship concentrate for beneficiation to China. That gives them a very good end price for the product. Iluka's biggest problem as I see it is the huge cost of beneficiation in Australia. Most of this cost is caused by government rules and regulations.
